跳至主要内容
临床试验/CTRI/2022/06/043515
CTRI/2022/06/043515尚未招募3 期

A Randomized Placebo Controlled Trial of Probiotics to Reduce the Severity of Mucositis Induced by Concurrent Chemoradiotherapy (CCRT) in Patients of Head & Neck and Pelvic Malignancies.

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Biopsy proven cases of Head & Neck Cancers (HNCs) and pelvic malignancies including Carcinoma Cervix, Carcinoma Urinary Bladder & Carcinoma Anorectum
  • 2.Age >=18 years
  • 3.Karnofsky Performance Status (KPS) > 60%
  • 4.No prior mucositis
  • 5.No prior history of chemo/radiotherapy administration
  • 6.No prior probiotics and/or antibiotics intake (at least within preceding 15 days) study)

排除标准

  • 1.Patients who refuse to give their consent
  • 2.Serious co-morbid diseases
  • 3.Prostate and colon malignancies (different treatment modalities)
  • 4.History of any prior cancer, or coexisting tumors (2nd primaries)
  • 5.Prior treatment history (Chemo/radiotherapy/surgery)
  • 6.Patients with Immunity diseases (Autoimmunity/ Immunodeficiency)
  • 7.Inability to take medicine orally or absorb medicine in GIT
  • 8.Allergy to probiotics.

研究者

相似试验

se of Probiotics in preventing Side Effects of... | 临床试验